| ABCA1 | ATP-binding cassette transporter A1 |
| AMPK | adenosine monophosphate-activated protein kinase |
| AOX | antioxidant |
| ARB | angiotensin II receptor blockers |
| BMI | body mass index |
| CAD | coronary artery disease |
| CI | confidence intervals |
| CRP | C-reactive protein |
| CVD | cardiovascular diseases |
| DPP4i | dipeptidyl peptidase-4 inhibitors |
| GLUT-4 | glucose transporter-4 |
| G6Pase | glucose-6-phosphatase |
| eNOS | endothelial nitric oxide synthase |
| FA | fatty acid |
| FFA | free fatty acids |
| GLP-1 | glucagon-like peptide-1 |
| HDL | high-density lipoprotein |
| HMW | high-molecular weight |
| HL | hepatic lipase |
| HOMA-IR | homeostasis model assessment of insulin resistance |
| HR | hazard ratio |
| HSL | hormone-sensitive lipase |
| IDL | intermediate-density lipoprotein |
| IL | interleukin |
| iNOS | inducible nitric oxide synthase |
| LDL | low-density lipoprotein |
| LPL | lipoprotein lipase |
| MCS | mixed-carotenoid supplementation |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NF-κB | nuclear factor-κB |
| NO | nitric oxide |
| PCOS | polycystic ovary syndrome |
| PPAR | peroxisome proliferator-activated receptor |
| PEPCK | phosphoenolpyruvate carboxy kinase |
| RCTs | randomized controlled trials |
| S1P | sphingosine 1-phosphate |
| Sd-LDL | small dense LDL |
| SGLT-2i | sodium–glucose cotransporter 2 inhibitors |
| SMCs | smooth muscle cells |
| SMD | standard mean difference |
| SR | scavenger receptor |
| TNF-α | tumor necrosis factor-alpha |
| TG | triglycerides |
| VLDL | very low density lipoprotein |
| VLDL-R | very low density lipoprotein receptor |
| WMD | weighted mean difference |